Related Experiment Video
Updated: Feb 16, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Next generation sequencing: clinical applications in solid tumours
1Department of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Next generation sequencing (NGS) is revolutionizing cancer diagnostics and treatment. This technology identifies genetic alterations for personalized cancer therapies and disease monitoring.
Area of Science:
- Oncology
- Genomics
- Molecular Diagnostics
Background:
- Next generation sequencing (NGS) has elucidated genetic alterations driving cancer pathogenesis.
- NGS is increasingly adopted in routine clinical diagnostics for malignant tumors.
Purpose of the Study:
- To highlight the central role of NGS in modern cancer care.
- To underscore the utility of NGS in diagnosis, targeted therapy selection, resistance mechanism identification, and disease monitoring.
Main Methods:
- Review of current applications of NGS in clinical oncology.
- Analysis of NGS's impact on personalized cancer medicine.
Main Results:
- NGS provides critical insights into tumor molecular profiles.
- NGS facilitates the identification of actionable therapeutic targets.
- NGS aids in understanding and overcoming treatment resistance.
Conclusions:
- NGS is integral to implementing molecularly adapted cancer therapies.
- The integration of NGS enhances precision oncology and patient management.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016